6505--Allopurinol Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), National Acquisition Center, has awarded a contract valued at $17,786,862.00 to XLCARE PHARMACEUTICALS INC for the supply of Allopurinol Tablets. This award, under Solicitation Number 36E79725R0067, covers the period from May 30, 2026, to May 29, 2027.
Scope of Work
This contract is for the procurement of Allopurinol 100mg and 300mg tablets in various package sizes (100, 500, and 1000 tablets per bottle). The purpose is to serve as a supply source for the VA and Department of Defense (DoD) Pharmaceutical Prime Vendor (PPV) Programs, ensuring nationwide availability and achieving volume-based pricing. Key requirements from the original solicitation included specific packaging (e.g., safety caps, compatibility with automated dispensing units, no glass bottles), 11-digit National Drug Code (NDC) labeling, GS1-128 or HIBCC compliant barcoding, and adherence to Drug Supply Chain Security Act (DSCSA) requirements. Manufacturing facilities were required to have acceptable cGMP status with the FDA.
Contract & Timeline
- Award Number: 36E79726D0024
- Award Amount: $17,786,862.00
- Award Date: March 9, 2026
- Awardee: XLCARE PHARMACEUTICALS INC (UEI: MEAUS5WHBJJ7)
- Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements (from original solicitation)
- Period of Performance: May 30, 2026, to May 29, 2027 (as per award document). The original solicitation outlined a base ordering period of one year with four one-year option periods.
- Product Service Code (PSC): 6505 (Drugs And Biologicals)
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)
- Size Standard: 1300 Employees
Evaluation
The original solicitation stated that award would be made to the lowest price technically acceptable offer. Technical acceptability criteria included meeting product descriptions, NDC uniqueness, FDA approval, FDA cGMP compliance, and manufacturing facility clearance.
Contact Information
For inquiries related to the original solicitation or this award, the primary contact is Matthew Poulin, Contract Specialist, at Matthew.Poulin@va.gov or 708-786-5186.